Oncotelic Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch OTLC and buy or sell other stocks, ETFs, and their options commission-free!

About OTLC

Oncotelic Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of anti-vascular therapeutics for patients with cancer and sight-threatening eye diseases. It also develops OT-101 for various cancers and COVID-19, Artemisinin for COVID-19 and AI technologies for clinical development and manufacturing. 

CEO
Vuong Trieu
CEOVuong Trieu
Employees
40
Employees40
Headquarters
Agoura Hills, California
HeadquartersAgoura Hills, California
Founded
1988
Founded1988
Employees
40
Employees40

OTLC Key Statistics

Market cap
23.23M
Market cap23.23M
Price-Earnings ratio
-5.49
Price-Earnings ratio-5.49
Dividend yield
—
Dividend yield—
Average volume
65.07K
Average volume65.07K
High today
$0.0542
High today$0.0542
Low today
$0.0501
Low today$0.0501
Open price
$0.0501
Open price$0.0501
Volume
20.84K
Volume20.84K
52 Week high
$0.07
52 Week high$0.07
52 Week low
$0.017
52 Week low$0.017
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.